South San Francisco Spatial Biology Roadshow
NanoString is heading to South San Francisco! We invite you to an afternoon filled with presentations and discussions all about the future of spatial biology. Join us at our free event and network with spatial biology experts in the biotech central of the Pacific, South San Francisco, CA.
Guest speakers will share their results and discoveries obtained using the GeoMx Digital Spatial Profiler and CosMx Spatial Molecular Imager. Spatial leaders will discuss the future of spatial omics applications and NanoString’s latest innovations.
The event will conclude with a cocktail and hors d’oeuvre reception.
Presentations
Catalyze The Next Revolution Using Spatial Biology, Presented by Espy Anguiano, PhD, Scientific Market Development Director – BioPharma, NanoString Technologies
Detailed Mechanistic Understanding of Drug Activity by Combining Spatial Biology with Trackable Drug Microdosing in Patients with Solid Tumors, Presented by Dr. Richard Klinghoffer, Chief Executive Officer, Presage Biosciences
Advancements in GeoMx DSP Region of Interest Selection, Presented by Sandra Rost, PhD, Scientific Manager, Spatial ‘Omics Lab in Research Pathology, Genentech & Raj Jesudason, Spatial ‘Omics Analysis Lead, Genentech
Agenda
1:30 – 2:00 p.m. Registration & Check in (The Presentation Room)
2:00 – 4:00 p.m. Presentations
4:00 – 5:00 p.m. Networking & Happy Hour
Register now for this free event!
Speakers
Richard Klinghoffer, PhD
Chief Executive Officer, Presage Biosciences
Espy Anguiano, PhD, MS-MBA
Scientific Market Development Director for Biopharma, NanoString
Dr. Espy Anguiano, Scientific Market Development Director at NanoString, obtained her PhD in Biomedical Science from Baylor University and holds a dual MBA degree from Temple University. She has over 20 years of experience in translational and clinical biomarker research in both academic and industry settings. Dr. Anguiano is a biomarker technology subject matter expert and has led biomarker and biomarker technology strategies for many early- and late-phase clinical trials in oncology and non-oncology disease areas. In her current role at NanoString, she is responsible for enabling the successful adoption of bulk and spatial technologies in research activities supporting drug discovery and development.
Sandra Rost, PhD
Scientific Manager, Spatial ‘Omics Lab in Research Pathology, Genentech
